Journal Article (Erratum/Correction)

DKFZ-2026-00343

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Corrigendum to 'EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitors' [Biomed. Pharmacother. 192 (2025), 118704].

Haller, B. ; Richter, G. H.DKFZ* ; Wachtel, M. ; Schuler, L. ; Regina, C. ; Renz, B. ; Jens, M.DKFZ* ; Bechtold, I. ; Gadasheva, Y. ; Hamed, E. ; Kisele, S. ; Knoblauch, M. ; Koch, M. R. ; Lupar, D.DKFZ* ; Nakano, S. ; Pardon, K.DKFZ* ; Pärschke, P. J.DKFZ* ; Winter, C. ; Tölch, U. ; Schäfer, B. W. ; Banito, A.DKFZ* ; von Lüttichau, I. ; Hettmer, S.

2026
Elsevier Paris [u.a.]

Note: ISSN 0753-3322 / epub

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Berlin (BE01)
2. NWG Weichteilsarkome (B380)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2026

---

Database coverage:
; BIOSIS Previews ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection

---